Son Güncellemeler
-
In Antiviral Research, Delivery Matters as Much as the Drug ItselfIn the shadow of every viral outbreak lies a deeper challenge: how do we deliver therapeutics precisely, safely, and effectively to the cells that need them most? While vaccine development and antiviral discovery often dominate headlines, the unsung hero of modern virology may well be lipid-based drug delivery systems. These microscopic carriers—liposomes, lipid nanoparticles (LNPs), and...0 Yorumlar 0 hisse senetleri 511 Views 0 önizlemePlease log in to like, share and comment!
-
Immune Checkpoint Antibodies: The Next Chapter in Cancer ImmunotherapyWhen immune checkpoint antibodies first entered the clinic a decade ago, they were hailed as a revolution. Drugs targeting PD‑1 and CTLA‑4 rewrote the rules of oncology, offering durable responses in cancers once considered untreatable. Today, the story is less about discovery and more about refinement: how to manufacture these complex molecules at scale, how to test them in ever more realistic...0 Yorumlar 0 hisse senetleri 533 Views 0 önizleme
-
Beyond Decoration: The Hidden Language of GlycosylationThat simple statement captures why glycoproteins have become one of the most compelling frontiers in biomedical research. These sugar‑coated proteins are not passive ornaments; they are active messengers, shaping how cells talk, how the immune system responds, and how diseases unfold. When Sugar Codes Go Wrong Glycosylation in health and disease represents one of the most...0 Yorumlar 0 hisse senetleri 413 Views 0 önizleme
-
CRISPR Library Design and Nuclease Testing for Faster ScreensImprove CRISPR screening confidence with custom gRNA library design and nuclease activity measurement for gene editing, diagnostics, and therapeutic R&D. CRISPR-based screening has become a practical engine for functional genomics, target discovery, and gene therapy research. But the quality of a screen often depends on two upstream decisions: how well the guide RNA library is...0 Yorumlar 0 hisse senetleri 441 Views 0 önizleme
-
Deciphering the Cascade: The Vital Role of C3b Deposition in TherapyThe complement system acts as a double-edged sword. While it is a guardian of innate immunity, its uncontrolled activation—marked by the rapid opsonization of surfaces with C3b fragments—is a primary driver of tissue damage in rare diseases and chronic inflammation. For drug developers, the ability to precisely quantify C3b deposition is no longer just a laboratory...0 Yorumlar 0 hisse senetleri 458 Views 0 önizleme
-
B Cell Engineering Service for Anti-Leukemia Antibody DeliveryLeukemia is a generic term for cancers of the bone marrow and lymphatic system. Leukemia is the most common disease in adults over 55 years old, while it is also the most often cancer in children under 15 years old. There are four main types of leukemia, each named for the rate at which the disease progresses and worsens as well as the blood cell type affected. This approach will...0 Yorumlar 0 hisse senetleri 559 Views 0 önizleme
-
From Binding to Function: The New Era of Phage Display in Drug DiscoveryBiotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs. Functional Target Screening: Moving Beyond Binding Traditional phage display often...0 Yorumlar 0 hisse senetleri 486 Views 0 önizleme
-
B Cell Engineering Service for Anti-Sarcoma Antibody DeliverySarcomas is a malignant solid tumor with high heterogeneity, which includes a large number of unique subtypes, more than 60 types. In recent years, targeted therapy based on the molecular and genetic phenotype of individual sarcomas has been a promising option for the treatment of sarcomas, meanwhile, several drugs have been approved for use to treat sarcomas. Although some of the...0 Yorumlar 0 hisse senetleri 526 Views 0 önizleme
-
Phage Display Ushers in a New Era of Precision Antibody EngineeringAs biopharmaceutical pipelines expand and therapeutic modalities grow more complex, the demand for highly specific, reproducible, and customizable antibodies has never been greater. Two categories—post‑translational modification (PTM)–specific antibodies and anti‑idiotype (anti‑ID) antibodies—have become essential tools for both discovery research and regulated bioanalytical...0 Yorumlar 0 hisse senetleri 480 Views 0 önizleme
Daha Hikayeler